| Literature DB >> 28413580 |
Zheng Li1, Anisha A Gupte1, Anjun Zhang1, Dale J Hamilton1.
Abstract
Cardiovascular diseases (CVDs) are the leading cause of death worldwide and represent a great challenge for modern research and medicine. Despite advances in preventing and treating CVD over the decades, there remains an urgent need to develop sensitive and safe methods for early detection and personalized treatment. With refinements of molecular imaging technologies such as positron emission tomography (PET), noninvasive imaging of CVDs is experiencing impressive progress in both preclinical and clinical settings. In this review, we summarize advances in cardiovascular PET imaging, highlight the latest development of CVD imaging probes, and illustrate the potential for individualized therapy based on metabolic phenotype.Entities:
Keywords: PET imaging; heart failure; metabolic imaging; personalized therapy
Mesh：
Substances：
Year: 2017 PMID： 28413580 PMCID： PMC5385792 DOI： 10.14797/mdcj-13-1-29
Source DB: PubMed Journal: Methodist Debakey Cardiovasc J ISSN： 1947-6108